From Casetext: Smarter Legal Research

Bone Care Int'l LLC v. Roxane Labs. Inc.

United States Court of Appeals for the Federal Circuit
Nov 7, 2012
2012-1525 (Fed. Cir. Nov. 7, 2012)

Opinion

2012-1525 2012-1526

11-07-2012

BONE CARE INTERNATIONAL LLC AND GENZYME CORPORATION, Plaintiffs-Appellees, v. ROXANE LABORATORIES INC., Defendant-Appellant, AND SANDOZ INC., Defendant-Appellant, AND ANCHEN PHARMACEUTICALS INC., Defendant.


NOTE: This order is nonprecedential.

Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0285, Chief Judge Gregory M. Sleet.

ON MOTION

ORDER

Bone Care International LLC and Genzyme Corporation move without opposition for a 5-day extension of time, until November 6, 2012, to file their response brief.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted.

FOR THE COURT

_________________

Jan Horbaly

Clerk
s21


Summaries of

Bone Care Int'l LLC v. Roxane Labs. Inc.

United States Court of Appeals for the Federal Circuit
Nov 7, 2012
2012-1525 (Fed. Cir. Nov. 7, 2012)
Case details for

Bone Care Int'l LLC v. Roxane Labs. Inc.

Case Details

Full title:BONE CARE INTERNATIONAL LLC AND GENZYME CORPORATION, Plaintiffs-Appellees…

Court:United States Court of Appeals for the Federal Circuit

Date published: Nov 7, 2012

Citations

2012-1525 (Fed. Cir. Nov. 7, 2012)